Blog
RSS FeedPosted by Michael Wonder on 04 Apr 2026
US hikes tariffs on Korean patented drugs, spares biosimilars for year
3 April 2026 - Korean drug makers eye US manufacturing labels and limited exemptions as Washington targets patented meds with new ...
Posted by Michael Wonder on 03 Apr 2026
Trump announces 100% tariffs on brand name drugs, with plenty of carveouts
2 April 2026 - The taxes won’t apply to many large drugmakers or to some of the US’ biggest trading ...
Posted by Michael Wonder on 03 Apr 2026
Butler ‘confident’ of CSL exemption as Australian drugs incur 100pc tariff
3 April 2026 - The Health Minister is hopeful the country’s largest biotech firm CSL will be exempt after Australia was ...
Posted by Michael Wonder on 02 Apr 2026
Trump puts Australia’s drugs scheme, digital rules in firing line
1 April 2026 - Donald Trump’s top trade tsar claims Australia’s unfair drug pricing practices are undermining US innovation, warns ...
Posted by Michael Wonder on 30 Mar 2026
Eli Lilly pushes for NHS drug price increases in return for its UK investment
30 March 2026 - US pharmaceutical group ‘optimistic’ about reaching deal with British Government. ...
Posted by Michael Wonder on 28 Mar 2026
The potential loophole in Trump’s plan to get other countries to pay more for drugs
24 March 2026 - Comments from a top health official point to a big issue. ...
Posted by Michael Wonder on 18 Mar 2026
Trump Promised the ‘World’s Lowest’ Drug Prices. We Checked the Numbers.
18 March 2026 - The TrumpRx website claims to offer the best prices for medications. Here’s where Americans still pay more ...
Posted by Michael Wonder on 12 Mar 2026
Health ministry cautious on timing of generic drug price cuts, reaffirms ‘no-exception’ principle
11 March 2026 - Amid mounting opposition from the pharmaceutical industry over the government's proposed “drug pricing system improvement plan,” ...
Posted by Michael Wonder on 07 Mar 2026
Trump’s drive to get Europe to pay more for drugs creates uncertainty for countries, patients
2 March 2026 - Pharma is also eager to see the region increase spending on medicines. ...
Posted by Michael Wonder on 06 Mar 2026
A month in, TrumpRx falls short of president’s grand promises
5 March 2026 - Few drugs, uneven savings mark early days of Trump’s discount medicines website. ...
Posted by Michael Wonder on 03 Mar 2026
ICER publishes special report on treatment for ulcerative colitis and Crohn’s disease as part of CMS public comment process on Medicare drug price negotiations
3 March 2026 - The ICER today posted a special report on Entyvio (vedolizumab, Takeda) for the treatment of ulcerative ...
Posted by Michael Wonder on 24 Feb 2026
Novo Nordisk announces significant reduction in US list price for Wegovy, Ozempic and Rybelsus (semaglutide medicines), building on continued efforts to expand access
24 February 2026 - Today, Novo Nordisk announced that, effective 1 January 2027, the company will lower the list price, ...
Posted by Michael Wonder on 18 Feb 2026
Biosimilar drug poses new test for Medicare price negotiations
12 February 2026 - A drug selected for the latest round of Medicare drug price negotiations stands to get dropped ...
Posted by Michael Wonder on 12 Feb 2026
Pharma group warns drug price cuts threaten industry investment
10 February 2026 - KPBMA demands postponement, impact assessments, and policy dialogue to protect R&D and health security amid pricing reforms. ...
Posted by Michael Wonder on 31 Jan 2026
This year drug makers cut prices for several widely used drugs
29 January 2026 - Companies raise prices for most medicines but federal government policy changes drive the reductions. ...